- Home
- TARA vs DSP Comparison
TARA vs DSP Comparison
Compare TARA & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | DSP |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.1M | 275.0M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TARA | DSP |
|---|---|---|
| Price | $3.84 | $12.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $24.40 | $17.81 |
| AVG Volume (30 Days) | ★ 367.3K | 305.7K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.25 | ★ 157.14 |
| EPS | N/A | ★ N/A |
| Revenue | $2,948,000.00 | ★ $344,201,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $16.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $3.02 | $8.11 |
| 52 Week High | $7.82 | $14.80 |
Technical Indicators
Market Signals| Indicator | TARA | DSP |
|---|---|---|
| Relative Strength Index (RSI) | 39.68 | 49.81 |
| Support Level | $3.73 | $10.77 |
| Resistance Level | $4.20 | $12.61 |
| Average True Range (ATR) | 0.15 | 0.80 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 15.19 | 17.72 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.